Bax:Bcl2 Cancer Research Results
Bax:Bcl2, Bax:Bcl2 ratio: Click to Expand ⟱
| Source: |
| Type: |
Bax and Bcl-2 are the major members of Bcl-2 family that play a key role in tumor progression or inhibition of intrinsic apoptotic pathway triggered by mitochondrial dysfunction.
Bax/Bcl-2 ratio is typically significantly lower in tumors.
|
Liver, Liver Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
TumCG↓, Apoptosis↓, Casp3↓, cl‑PARP↑, Bcl-2↓, p‑ERK↓, p‑p38↑, *Bacteria↓, *AntiAg↑, *Inflam↓, *antiOx↑, *AChE↓, AntiTum↑, MMP↓, Cyt‑c↑, Bax:Bcl2↑, Casp↑, DNAdam↑, selectivity↑,
ROS↑, P53↑, MMP↓, Bax:Bcl2↑, Apoptosis↑, *Bacteria↓, MDA↑, GSH↓, eff↓, Casp3↑,
ROS↑, P53↑, TumCCA↑, IL6↓, COX2/PTGS2↓, TNF-α↓, MMP↓, angioG↓, MMP9↓, BAX↑, Casp3↑, Apoptosis↑, RadioS↑, TBARS↑, GSH↓, Bax:Bcl2↑, p‑NF-kB↓, p‑STAT3↓,
ROS↑, CHOP/DDIT3↑, MMP↓, Bax:Bcl2↑, Casp8↑, Casp3↑, Casp9↑, cl‑PARP↑, DFF45↑,
TumCD↑, selectivity↑, *toxicity↓, cl‑PARP↑, DNAdam↑, Bax:Bcl2↑, MMP↓, Cyt‑c↑, Casp3↑, ROS↑, NO↑, p‑Akt↓, FOXO4↑, eff↓,
| - |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
Liver, |
HUH7 |
|
|
|
tumCV↓, Apoptosis↑, TumAuto↑, AMPK↑, TumCG↓, ATG5↑, Beclin-1/ATG6↑, p‑mTOR↓, Casp3↑, cl‑PARP↑, Bax:Bcl2↑, LC3II↑, p62↓,
Showing Research Papers: 1 to 6 of 6
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 6
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
GSH↓, 2, MDA↑, 1, ROS↑, 4, TBARS↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↓, 5,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↑, 1,
Cell Death(tgid=5) ⓘ
p‑Akt↓, 1, Apoptosis↓, 1, Apoptosis↑, 3, BAX↑, 1, Bax:Bcl2↑, 6, Bcl-2↓, 1, Casp↑, 1, Casp3↓, 1, Casp3↑, 5, Casp8↑, 1, Casp9↑, 1, Cyt‑c↑, 2, p‑p38↑, 1, TumCD↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
CHOP/DDIT3↑, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
ATG5↑, 1, Beclin-1/ATG6↑, 1, LC3II↑, 1, p62↓, 1, TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
DFF45↑, 1, DNAdam↑, 2, P53↑, 2, cl‑PARP↑, 4,
Cell Cycle & Senescence(tgid=11) ⓘ
TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
p‑ERK↓, 1, FOXO4↑, 1, p‑mTOR↓, 1, p‑STAT3↓, 1, TumCG↓, 2,
Migration(tgid=13) ⓘ
MMP9↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1, NO↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↓, 1, IL6↓, 1, p‑NF-kB↓, 1, TNF-α↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
eff↓, 2, RadioS↑, 1, selectivity↑, 2,
Clinical Biomarkers(tgid=22) ⓘ
IL6↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiTum↑, 1,
Total Targets: 49
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1,
Migration(tgid=13) ⓘ
AntiAg↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1,
Synaptic & Neurotransmission(tgid=18) ⓘ
AChE↓, 1,
Functional Outcomes(tgid=23) ⓘ
toxicity↓, 1,
Infection & Microbiome(tgid=24) ⓘ
Bacteria↓, 2,
Total Targets: 6
Scientific Paper Hit Count for: Bax:Bcl2, Bax:Bcl2 ratio
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:14 Cells:% prod#:% Target#:352 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page